PTC Therapeutics Inc (PTCT)

Boulding Mark Elliott 🟡 adjusted position in 6.6K shares (2 derivative) of PTC THERAPEUTICS, INC. (PTCT) at $78.98 Transaction Date: Jan 06, 2026 | Filing ID: 000004

Register to leave comments

  • News bot Jan. 8, 2026, 10:23 p.m.

    🔍 Boulding Mark Elliott (Executive)

    Company: PTC THERAPEUTICS, INC. (PTCT)

    Report Date: 2026-01-06

    Transaction Summary:

    • Total transactions: 12
    • Derivative instruments: 2
    • Holdings reported: 0
    • Total shares acquired: 3,376
    • Total shares sold: 9,996

    Detailed Transactions and Holdings:

    • Sold 1,739 shares of Common Stock at $76.95 per share (Direct)
      Date: 2026-01-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 119,162.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 1,503 shares of Common Stock at $77.48 per share (Direct)
      Date: 2026-01-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 117,659.00 | transaction_form_type: 4 | Footnotes: F2
    • Acquired 2,625 shares of Common Stock at $38.1 per share (Direct)
      Date: 2026-01-07 | Code: M | equity_swap_involved: 0 | shares_owned_after: 120,284.00 | transaction_form_type: 4 | Footnotes: F3
    • Sold 1,638 shares of Common Stock at $77.11 per share (Direct)
      Date: 2026-01-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 118,646.00 | transaction_form_type: 4 | Footnotes: F3, F4
    • Sold 949 shares of Common Stock at $77.91 per share (Direct)
      Date: 2026-01-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 117,697.00 | transaction_form_type: 4 | Footnotes: F3, F5
    • Sold 38 shares of Common Stock at $78.6 per share (Direct)
      Date: 2026-01-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 117,659.00 | transaction_form_type: 4 | Footnotes: F3
    • Acquired 751 shares of Common Stock at $38.1 per share (Direct)
      Date: 2026-01-07 | Code: M | equity_swap_involved: 0 | shares_owned_after: 118,410.00 | transaction_form_type: 4 | Footnotes: F3
    • Sold 471 shares of Common Stock at $77.1 per share (Direct)
      Date: 2026-01-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 117,939.00 | transaction_form_type: 4 | Footnotes: F3, F6
    • Sold 269 shares of Common Stock at $77.92 per share (Direct)
      Date: 2026-01-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 117,670.00 | transaction_form_type: 4 | Footnotes: F3, F7
    • Sold 11 shares of Common Stock at $78.98 per share (Direct)
      Date: 2026-01-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 117,659.00 | transaction_form_type: 4 | Footnotes: F3
    • Sold 2,627 shares of Stock Option (Right to Buy) at $38.1 per share (Derivative)
      Date: 2026-01-07 | Code: M | Expires: 2032-01-06 | equity_swap_involved: 0 | shares_owned_after: 751.00 | transaction_form_type: 4 | Footnotes: F3, F8
    • Sold 751 shares of Stock Option (Right to Buy) at $38.1 per share (Derivative)
      Date: 2026-01-07 | Code: M | Expires: 2032-01-06 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3, F8

    Footnotes:

    • F1: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 4,500 RSUs from a January 3, 2025 grant of 18,000 RSUs.
    • F2: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 4,250 RSUs from a January 5, 2023 grant of 17,000 RSUs.
    • F3: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 4, 2024.
    • F4: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $76.56 to $77.55 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
    • F5: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $77.58 to $78.54 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
    • F6: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $76.54 to $77.52 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
    • F7: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $77.54 to $78.47 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
    • F8: Currently exercisable.